Walker, A. Et Al. 2022. International society of oncology pharmacy practitioners (ISOPP) position statement: The role of oncology pharmacy practitioners in immunotherapy treatment with immune checkpoint inhibitors for malignant conditions. JOURNAL OF ONCOLOGY PHARMACY PRACTICE .

Walker, A., Chan, A., Labra, C. C., de Lemos, M. L., Geirnaert, M., Albert-Mari, M. A., ... Atik, E. A.(2022). International society of oncology pharmacy practitioners (ISOPP) position statement: The role of oncology pharmacy practitioners in immunotherapy treatment with immune checkpoint inhibitors for malignant conditions. JOURNAL OF ONCOLOGY PHARMACY PRACTICE .

Walker, Andrew Et Al. "International society of oncology pharmacy practitioners (ISOPP) position statement: The role of oncology pharmacy practitioners in immunotherapy treatment with immune checkpoint inhibitors for malignant conditions," JOURNAL OF ONCOLOGY PHARMACY PRACTICE , 2022

Walker, Andrew Et Al. "International society of oncology pharmacy practitioners (ISOPP) position statement: The role of oncology pharmacy practitioners in immunotherapy treatment with immune checkpoint inhibitors for malignant conditions." JOURNAL OF ONCOLOGY PHARMACY PRACTICE , 2022

Walker, A. Et Al. (2022) . "International society of oncology pharmacy practitioners (ISOPP) position statement: The role of oncology pharmacy practitioners in immunotherapy treatment with immune checkpoint inhibitors for malignant conditions." JOURNAL OF ONCOLOGY PHARMACY PRACTICE .

@article{article, author={Andrew Walker Et Al. }, title={International society of oncology pharmacy practitioners (ISOPP) position statement: The role of oncology pharmacy practitioners in immunotherapy treatment with immune checkpoint inhibitors for malignant conditions}, journal={JOURNAL OF ONCOLOGY PHARMACY PRACTICE}, year=2022}